A dose parallel, randomized, placebo-controlled, multicenter study of the safety and efficacy of multiple regimens of the combination of zonisamide CR plus bupropion SR in the treatment of subjects with uncomplicated obesity

Trial Profile

A dose parallel, randomized, placebo-controlled, multicenter study of the safety and efficacy of multiple regimens of the combination of zonisamide CR plus bupropion SR in the treatment of subjects with uncomplicated obesity

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Oct 2008

At a glance

  • Drugs Bupropion/zonisamide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Sponsors Orexigen Therapeutics
  • Most Recent Events

    • 06 Oct 2008 Long-term (over 48 weeks) data presented at the Obesity Society Annual Scientific Meeting.
    • 09 May 2008 48-week results were reported in January 2008.
    • 08 Jan 2008 Results data for 24-week extension study (total 48-week study duration) available.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top